View printer-friendly version |
Charles River Laboratories to Present at June Investor Conferences
-
Jefferies 2013 Global Healthcare Conference in
New York, New York onWednesday, June 5 th, at9:30 a.m. EDT ; -
Goldman Sachs 34th Annual Global Healthcare Conference inRancho Palos Verdes, California onTuesday, June 11 th, at10:00 a.m. PDT (1:00 p.m. EDT ); and -
Wells Fargo Securities 2013 Healthcare Conference inBoston, Massachusetts onWednesday, June 19 th, at10:05 a.m. EDT .
Management will present an overview of Charles River’s strategic focus and business developments.
A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website approximately three hours after each presentation and will remain available for approximately two weeks.
About Charles River
Accelerating Drug Development. Exactly. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
Source:
Charles River Laboratories International, Inc.
Investor Relations
Contact:
Susan E. Hardy, 781-222-6190
Corporate Vice
President, Investor Relations
susan.hardy@crl.com